123.62
+1.82
+(1.49%)
At close: January 17 at 3:37:05 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 8 | 16 | 16 |
| Avg. Estimate | 4.86B | 4.99B | 20B | 19.9B |
| Low Estimate | 4.81B | 4.84B | 19.94B | 19.07B |
| High Estimate | 4.92B | 5.13B | 20.11B | 20.66B |
| Year Ago Sales | 4.97B | 5.15B | 20.43B | 20B |
| Sales Growth (year/est) | -2.29% | -3.08% | -2.13% | -0.48% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KMY.F | -- | -- | -- | -- |
| S&P 500 | 9.26% | 11.36% | 13.91% | 13.52% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 1/17/2025 |
| Maintains | UBS: Neutral to Neutral | 1/16/2025 |
| Maintains | JP Morgan: Underweight to Underweight | 1/16/2025 |
| Maintains | Citigroup: Sell to Sell | 1/15/2025 |
| Downgrade | TD Cowen: Buy to Hold | 1/8/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/7/2025 |